MADRIGAL PHARMACEUTICALS, INC. (MDGL) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2008: -$58.79M2009: $24.91M2010: $23.48M2011: $14.77M2012: $75.07M2013: $49.09M2014: -$42.07M2015: -$48.91M2016: $36.41M2017: $182.26M2018: $476.98M2019: $416.56M2020: $239.97M2021: $196.11M2022: $197.39M2023: $405.33M2024: $754.38M2025: $602.69M$602.69M
2008Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$602.69M-20.1%
2024$754.38M+86.1%
2023$405.33M+105.3%
2022$197.39M+0.7%
2021$196.11M-18.3%
2020$239.97M-42.4%
2019$416.56M-12.7%
2018$476.98M+161.7%
2017$182.26M+400.6%
2016$36.41M+174.4%
2015-$48.91M-16.3%
2014-$42.07M-185.7%
2013$49.09M-34.6%
2012$75.07M+408.1%
2011$14.77M-37.1%
2010$23.48M-5.7%
2009$24.91M+142.4%
2008-$58.79M